Results 171 to 180 of about 33,667 (245)

Mechanisms for Mineralocorticoid-Driven Age-Related Hypertension: Potential Therapeutic Role of Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors. [PDF]

Circ Res
Golec S, Vaidya A, Pitt B, Jaffe IZ.
europepmc   +1 more source

Spironolactone and clinical outcomes in patients with alcohol use disorder and comorbid hypertension: a target trial emulation study. [PDF]

Psychopharmacology (Berl)
Loften A, Wang Q, Farokhnia M, Kaelber DC, Volkow ND, Vendruscolo LF, Xu R, Leggio L.   +7 more
europepmc   +1 more source

Spironolactone Treatment for Dermatologic Conditions is Associated With Blood Pressure Changes in Patients on Concomitant Antihypertensives: A Retrospective Cohort Study. [PDF]

Int J Dermatol
Chan R, Neubauer Z, Ong MM, Chernoff KA, Lipner SR.   +4 more
europepmc   +1 more source

Finerenone vs. spironolactone to reduce adverse outcomes in patients with cardiac-kidney-metabolic syndrome complicated by atrial fibrillation: findings from the Tianjin atrial fibrillation project. [PDF]

Eur Heart J Open
Tian X, Liu X, Zhao J, Han X, Gu T, Chen KY, Korantzopoulos P, Lip GYH, Liu T.   +8 more
europepmc   +1 more source

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review. [PDF]

Heart Fail Rev
Van Spall HGC, Vardeny O.
europepmc   +1 more source

Acne vulgaris: a clinical update. [PDF]

Aust Prescr
Iyengar L, Welsh B.
europepmc   +1 more source

A rare genetically confirmed case of apparent mineralocorticoid excess syndrome due to a homozygous HSD11B2 variant in a 2-year-old child with severe hypertension: response to targeted therapy. [PDF]

Clin Exp Pediatr
Alabbasi B, Elamin M, Alsallum G, Alzahrany G.   +3 more
europepmc   +1 more source

The impact of mineralocorticoid receptor antagonists on fat mass and fat metabolism. [PDF]

J Endocrinol Invest
Afsar B, Afsar RE, Maddukuri G.
europepmc   +1 more source

Diuretic therapy for critically ill patients: a systematic review and network meta-analysis. [PDF]

Ann Intensive Care
Kuriyama A, Polok K, Malhotra N, Kuse N, Pitre T, Lakhanpal D, Sun R, Soni KD, Campbell K, Burry LD, Clark EG, Lewis K, Møller MH, Gershengorn HB, Rochwerg B.   +14 more
europepmc   +1 more source

Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space. [PDF]

J Am Heart Assoc
Jelwan Y, Cao T, Yao Z, Burka S, Erhabor J, Berning P, Dzaye O, Blaha M.   +7 more
europepmc   +1 more source